Candel Therapeutics, Inc. CADL NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

49/100

2/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Candel Therapeutics, Inc. (CADL), dont 34 achats et 15 ventes. Le total des achats d'initiés s'élève à $26.12M et le total des ventes d'initiés à $1.25M.

Les initiés notables ayant une activité récente comprennent Papa Joseph C, Manning Paul B, Loggia Nicoletta. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — CADL

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-31	Papa Joseph C	Director	Attribution de RSU	2,795	$4.90	$13.7K	2,795
2026-03-31	Manning Paul B	Director	Attribution de RSU	4,618	$4.90	$22.63K	4,618
2026-03-31	Loggia Nicoletta	Director	Attribution de RSU	779	$4.90	$3.82K	779
2026-02-23	Manning Paul B	Director	Achat Informatif	550,458	$5.45	$3M	2,763,527
2026-01-26	Nichols William Garrett	Chief Medical Officer	Attribution de RSU	136,500	$6.01	$820.37K	136,500
2026-01-26	Tak Paul Peter	Chief Executive Officer	Attribution de RSU	629,000	$6.01	$3.78M	629,000
2026-01-26	Barone Francesca	Chief Scientific Officer	Attribution de RSU	232,000	$6.01	$1.39M	232,000
2026-01-26	Tyagarajan Seshu	Chief Technology Officer	Attribution de RSU	154,000	$6.01	$925.54K	154,000
2026-01-26	Schoch Charles	Chief Financial Officer	Attribution de RSU	232,000	$6.01	$1.39M	232,000
2025-07-28	Nichols William Garrett	Chief Medical Officer	Exercice d'Options (Vente)	937	$1.29	$1.21K	29,377
2025-06-30	Nichols William Garrett	Chief Medical Officer	Exercice d'Options (Vente)	781	$1.29	$1.01K	30,314
2025-06-25	Papa Joseph C	Director	Attribution de RSU	64,239	$4.67	$300K	64,239
2025-06-25	Manning Paul B	Director	Attribution de RSU	1,070,663	$4.67	$5M	2,213,069
2025-06-25	Nabel Gary J.	Director	Attribution de RSU	5,353	$4.67	$25K	5,353
2025-06-25	Martell Christopher	Director	Attribution de RSU	111,349	$4.67	$520K	111,349
2025-06-25	Tak Paul Peter	Chief Executive Officer	Attribution de RSU	42,826	$4.67	$200K	268,566
2025-06-25	Barone Francesca	Chief Scientific Officer	Attribution de RSU	4,282	$4.67	$20K	100,809
2025-06-25	Tyagarajan Seshu	Chief Technology Officer	Attribution de RSU	5,353	$4.67	$25K	90,865
2025-06-25	Loggia Nicoletta	Director	Attribution de RSU	2,141	$4.67	$10K	2,141
2025-06-25	Schoch Charles	Chief Financial Officer	Attribution de RSU	5,353	$4.67	$25K	43,391
2025-06-20	Schoch Charles	Chief Financial Officer	Attribution de RSU	50,000	$4.75	$237.5K	50,000
2025-06-17	Papa Joseph C	Director	Attribution de RSU	14,240	$4.94	$70.35K	14,240
2025-06-17	Manning Paul B	Director	Attribution de RSU	14,240	$4.94	$70.35K	14,240
2025-06-17	Benz Edward J. Jr	Director	Attribution de RSU	14,240	$4.94	$70.35K	14,240
2025-06-17	Gaeta Renee	Director	Attribution de RSU	14,240	$4.94	$70.35K	14,240
2025-06-17	Nguyen Diem	Director	Attribution de RSU	14,240	$4.94	$70.35K	14,240
2025-06-17	Nabel Gary J.	Director	Attribution de RSU	14,240	$4.94	$70.35K	14,240
2025-06-17	Martell Christopher	Director	Attribution de RSU	14,240	$4.94	$70.35K	14,240
2025-06-17	Loggia Nicoletta	Director	Attribution de RSU	14,240	$4.94	$70.35K	14,240
2025-06-04	Radhakrishnan Maha	Officer	Inconnu	-	-	-	-
2025-06-04	Radhakrishnan Maha	Director	Attribution de RSU	28,480	$5.60	$159.49K	28,480
2025-03-19	Tak Paul Peter	Chief Executive Officer	Vente Informative	400	$9.00	$3.6K	225,740
2025-03-18	Nichols William Garrett	Chief Medical Officer	Exercice d'Options (Vente)	13,905	$1.29	$17.94K	31,095
2025-03-18	Tak Paul Peter	Chief Executive Officer	Vente Informative	25,772	$8.77	$226.02K	226,140
2025-03-18	Barone Francesca	Chief Scientific Officer	Exercice d'Options (Vente)	18,000	$1.55	$27.9K	30,822
2025-03-17	Tyagarajan Seshu	Chief Technology Officer	Exercice d'Options (Vente)	20,000	$1.29	$25.8K	70,000
2025-03-17	Schoch Charles	See Remarks	Vente Informative	5,000	$8.83	$44.17K	38,038
2025-03-17	Tyagarajan Seshu	Chief Technology Officer	Exercice d'Options	20,000	$1.29	$25.8K	116,790
2025-02-21	Aguilar-cordova Estuardo	10 Percent Owner	Restitution d'Actions	10,582	$12.02	$127.2K	120,861
2025-02-12	Nichols William Garrett	Chief Medical Officer	Attribution de RSU	107,250	$8.55	$916.99K	107,250
2025-02-12	Tak Paul Peter	Chief Executive Officer	Attribution de RSU	525,000	$8.55	$4.49M	525,000
2025-02-12	Barone Francesca	Chief Scientific Officer	Attribution de RSU	115,000	$8.55	$983.25K	115,000
2025-02-12	Tyagarajan Seshu	Chief Technology Officer	Attribution de RSU	65,000	$8.55	$555.75K	65,000
2025-02-12	Schoch Charles	See Remarks	Attribution de RSU	83,000	$8.55	$709.65K	83,000
2025-02-10	Aguilar-cordova Estuardo	10 Percent Owner	Restitution d'Actions	31,335	$8.61	$269.79K	60,000
2025-01-15	Nichols William Garrett	Chief Medical Officer	Vente Informative	10,428	$7.23	$75.34K	79,320
2025-01-15	Tak Paul Peter	Chief Executive Officer	Vente Informative	21,704	$7.23	$156.81K	251,912
2025-01-15	Barone Francesca	Chief Scientific Officer	Vente Informative	13,534	$7.23	$97.78K	110,673
2025-01-15	Tyagarajan Seshu	Chief Technology Officer	Vente Informative	14,322	$7.23	$103.48K	96,790
2025-01-15	Schoch Charles	See Remarks	Vente Informative	9,511	$7.23	$68.72K	43,038

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration